Literature DB >> 17761594

Mechanisms of anabolic therapies for osteoporosis.

Ernesto Canalis1, Andrea Giustina, John P Bilezikian.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17761594     DOI: 10.1056/NEJMra067395

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  219 in total

Review 1.  T cells: critical bone regulators in health and disease.

Authors:  Roberto Pacifici
Journal:  Bone       Date:  2010-05-07       Impact factor: 4.398

Review 2.  Osteoblastogenesis regulation signals in bone remodeling.

Authors:  C Zuo; Y Huang; R Bajis; M Sahih; Y-P Li; K Dai; X Zhang
Journal:  Osteoporos Int       Date:  2012-06       Impact factor: 4.507

3.  Bone healing: little secrets.

Authors:  Thomas A Einhorn
Journal:  Clin Cases Miner Bone Metab       Date:  2011-01

4.  Notch signaling in osteocytes differentially regulates cancellous and cortical bone remodeling.

Authors:  Ernesto Canalis; Douglas J Adams; Adele Boskey; Kristen Parker; Lauren Kranz; Stefano Zanotti
Journal:  J Biol Chem       Date:  2013-07-24       Impact factor: 5.157

Review 5.  Body composition and skeletal health: too heavy? Too thin?

Authors:  Alexander Faje; Anne Klibanski
Journal:  Curr Osteoporos Rep       Date:  2012-09       Impact factor: 5.096

6.  Caffeine inhibits the viability and osteogenic differentiation of rat bone marrow-derived mesenchymal stromal cells.

Authors:  Y Zhou; X X Guan; Z L Zhu; J Guo; Y C Huang; W W Hou; H Y Yu
Journal:  Br J Pharmacol       Date:  2010-12       Impact factor: 8.739

7.  Teriparatide increases strength of the peripheral skeleton in premenopausal women with idiopathic osteoporosis: a pilot HR-pQCT study.

Authors:  Kyle K Nishiyama; Adi Cohen; Polly Young; Ji Wang; Joan M Lappe; X Edward Guo; David W Dempster; Robert R Recker; Elizabeth Shane
Journal:  J Clin Endocrinol Metab       Date:  2014-03-31       Impact factor: 5.958

Review 8.  Glucocorticoids and the regulation of growth hormone secretion.

Authors:  Gherardo Mazziotti; Andrea Giustina
Journal:  Nat Rev Endocrinol       Date:  2013-02-05       Impact factor: 43.330

9.  Effects of bone remodeling agents following teriparatide treatment.

Authors:  D Burkard; T Beckett; E Kourtjian; C Messingschlager; R Sipahi; M Padley; J Stubbart
Journal:  Osteoporos Int       Date:  2018-03-14       Impact factor: 4.507

Review 10.  Osteoblast dysfunctions in bone diseases: from cellular and molecular mechanisms to therapeutic strategies.

Authors:  Pierre J Marie
Journal:  Cell Mol Life Sci       Date:  2014-12-09       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.